Novel Esters and Amides Derived from Indolealkanol and Indolealkylamines as Selective Cyclooxygenase-2 (Cox-2) Inhibitors


Patents protecting this technology have been issued in the U.S., Israel, and Europe.

U.S. Patent 6,306,890: Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors

Amit KalgutkarLawrence Marnett
Licensing manager: 
Mike Villalobos

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter